November 9, 2009
This guide aims to provide pharma marketers with an overview of the key challenges surrounding Direct-to-Consumer (DTC) online marketing and some potential solutions for effectively leveraging this channel within the complex regulatory environment.
 |
October 21, 2009
Lancaster Laboratories Professional Scientific StaffingSM service has been specifically designed to give you the non-permanent workforce you need for anywhere from one year to 10 years or more with no worries about co-employment and at lower costs than fixed headcounts.
|
September 8, 2009
By:Siperian, Inc.
Many state-level governments have adopted legislations that limit as well as mandate the disclosure of payments to physicians.
|
September 1, 2009
When it comes to Contracts and Chargebacks - the stakes are high - as credits for chargebacks can often exceed millions of dollars each month. If you find yourself faced with addressing changing regulatory requirements, managing hundreds of contracts, and validating and processing chargeback submissions, we encourage you to learn more in this white paper.
|
May 28, 2009
Information technology is finally up to the task of cost-effective clinical research. But there are still some significant barriers to gaining all the benefits of the technology, in particular, interoperability. This white paper explores the need for a consistent industry architecture that allows life sciences firms to connect their enterprises and benefit from unified data integration, process consistency and rapid communication of meaningful drug findings.
|
May 28, 2009
This solution brief explains how SAS solutions streamline and accelerate drug development through better data integration and analysis. The brief explains the features and benefits of the SAS framework and includes a case study documenting the success of a top ?ten pharmaceutical company using the solution.
|
May 28, 2009
This white paper shows how to develop, execute and manage the transformation, analysis and submission of clinical research data with SAS® Drug Development. It includes an executive summary that outlines current industry challenges. And, it answers the top ten questions life sciences executives confront when trying to balance innovation with regulatory compliance.
|
May 28, 2009
Concise Executive Guide to Business Analytics: Overview of business applications and payoffs, staff and technology requirements, and the roles executives must play to realize the performance potential of analytics. Six key questions are asked about how well information at hand is used to meet goals and innovate in the marketplace.
|
May 26, 2009
Because of their investment in intellectual property and the clinical trial information they generate, life sciences companies face greater security risks than other companies. This paper explores common business processes that put companies at risk and ways companies protect themselves.
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
Applying E-Commerce to Support Discovery and Development of Medicines: Key Lessons and Learnings Tuesday, December 15 @ 11:00 a.m. ET
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?